Hi, I'm new here. I’ve been following the thread about Pharmacom, and it seems like they’re continuing their business as if nothing happened here. How is that possible? I was just about to place an order on Basicstero.
How is it possible that Pharmacom Labs continues to succeed after this post?
Let me tell you: It's because there are no problems.
1) The topic was discussed thoroughly here and in the Basicstero thread, including SIMEC (
simec.ch) results on the same product that show it was good.
2) There was no more stock of that old batch on which further 3rd-party testing could be run to resolve the conflict (discrepancy between this result here and other analytic results for the same batch).
*Please note, I notice that it appears the result in question here was done on a blind sample (unknown product) so there is no way to be 100% certain regarding what sample was sent to be tested (there could have been some mistakes, including what was actually sent to be tested).
3) Pharmacom Labs is one of the biggest and most popular brands in the world that, as you mentioned, continues to do business successfully to this day. If there was a major problem, we would all noticed because there would be thousands of customers with a problem. Many years, well over a decade, of being know for great products, high quality, and thousands of satisfied customers, is a great reputation that speaks for itself.
So, the answer to your question is simple, there is no problem.
That's why Pharmacom Labs continues to be known for its high quality and excellent reputation which is reflected by the fact that the business is still going strong after all these years.
Please see the examples below of analytic results on more recent batches of AI products from Pharmacom Labs.
ANASTRAZOLOS: Anastrozole (Arimidex) from Pharmacom Labs
Analytic testing performed by Janoshik.
RESULTS:
1. Qualitative analysis: the sample contains the active ingredient Anastrozole.
2. Quantitative analysis showed the content of active ingredient: 1.02 mg.
Analysis conducted: 05 January 2024
EXOS: Exemestane from Pharmacom Labs
Analytic testing performed by Janoshik.
RESULTS:
1. Qualitative analysis: the sample contains the active ingredient Exemestane.
2. Quantitative analysis showed the content of active ingredient: 24.93 mg.
Analysis conducted: 05 January 2024
LETROS: Letrozole from Pharmacom Labs
Analytic testing performed by Janoshik.
RESULTS:
1. Qualitative analysis: the sample contains the active ingredient: Letrozole.
2. Quantitative analysis showed the content of active ingredient: 2.40 mg.
Analysis conducted: 16 June 2023
Also, below you can find some of the other details discussed in this topics including the SIMEC result for the same batch that was in question here:
@MadBret Here is the analytic result from SIMEC for that batch:
SIMEC testing show it is adex.
The source's testing shows it is adex.
Jano testing shows it is letro.
I respect both (and Frank has also stated he is not doubting Jano -- from what Frank wrote, it sounds like the source even paid to have it tested again with Jano).
I would appreciate if I could see what
ChemTox or another credible 3rd-party lab concludes. I know it is not practical and unlikely to occur; but, at this point I am also just interested to see additional results...
So, i got some info from our team. I have already posted it in our thread and will just copy-paste.
So, in my previous post I stated we are sure that anastrozol we have contains anastrozol, not letrozol. This is my point still. I do not have myself chemical background, so I could probably not completely understand all tiny testing details, but I will translate to you info provided by our specialist.
As explained earlier we ordered raws stock in advance due to rumors about possible raws lack in future. Those raws were tested and we use them in the current batch we have in stock...